Related Experiment Video
Updated: Jun 13, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
[Regeneration therapy by cell transplantation for acute coronary syndrome]
Satoaki Matoba1, Hideo Nakamura, Hiroaki Matsubara
1Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
Insights
Cell therapy offers a promising treatment for acute coronary syndrome (ACS) refractory to traditional methods. Ongoing research is evaluating adult stem cells for heart repair, focusing on safety, feasibility, and optimal strategies for ACS patients.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Context:
- Ischemic heart disease remains a primary cause of mortality globally.
- Modern reperfusion strategies for acute coronary syndrome (ACS) have limitations.
- Conventional treatments are often insufficient for refractory ischemic heart disease.
Purpose:
- To explore cell therapy as a viable treatment for ischemic heart disease.
- To investigate the safety and feasibility of adult stem cell therapy in clinical settings.
- To determine optimal cell therapy strategies for patients with ACS.
Summary:
- Adult stem cells are being investigated for their potential in repairing heart tissue.
- Clinical studies indicate that cell therapy for ACS is safe and feasible.
- Further research is needed to elucidate the precise mechanisms of cardiac repair via stem cells.
Impact:
- Cell therapy presents a novel therapeutic avenue for patients with severe ischemic heart disease.
- Advancements in cell therapy could significantly reduce mortality associated with ACS.
- Large-scale studies are crucial for establishing evidence-based guidelines for cell therapy in cardiology.
Abstract:
Despite a great progress of modern reperfusion strategies in acute coronary syndrome (ACS), ischemic heart disease is still a leading course of mortality in the developed countries. Cell therapy is a promising option to treat ischemic heart disease refractory to conventional treatments. In particular, adult stem cells have been identified and used to clinical cases. Although the detail mechanisms to repair adult heart need further investigation, several clinical studies suggest its safety and feasibility. Current large-scale randomized study will reveal optimal strategy of cell therapy for the patients with ACS.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:28Acute Coronary Syndrome IV: Interprofessional Care